Yifeng Pharmacy Chain Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Gao Yi
Chief executive officer
CN¥2.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 11.7% |
| Management average tenure | no data |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
Market Still Lacking Some Conviction On Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939)
Feb 07
We Think Yifeng Pharmacy Chain (SHSE:603939) Can Stay On Top Of Its Debt
Jan 17Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled
Dec 12We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings
Nov 06The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More
Sep 27Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)
Jul 29Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch
Jun 20Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly
May 24Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors
May 06Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?
Apr 13Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings
Mar 28Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price
Mar 13CEO
Gao Yi (57 yo)
Mr. Gao Yi serves as the Chairman of the Board and Chief Executive Officer at Yifeng Pharmacy Chain Co., Ltd. and served as its President.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥2.88m | 11.67% CN¥ 3.4b | |
| Executive President & Director | no data | CN¥2.54m | 0.012% CN¥ 3.6m | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Director | no data | CN¥1.41m | no data | |
| Director | 1.4yrs | no data | no data | |
| Supervisor | no data | no data | no data | |
| Independent Director | no data | CN¥60.00k | no data | |
| Director | 1.4yrs | CN¥200.00k | no data | |
| Director | 1.4yrs | CN¥100.00k | no data | |
| Independent Director | 1.4yrs | CN¥60.00k | no data | |
| Independent Director | 1.4yrs | CN¥60.00k | no data | |
| Employee Supervisor Representative | 1.4yrs | no data | no data |
Experienced Board: 603939's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 15:06 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yifeng Pharmacy Chain Co., Ltd. is covered by 23 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Qianyi Li | China International Capital Corporation Limited |
| Bing Zhao | China Renaissance Securities |